ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 420521 | Rec_0433179 | Yodha |
SMLLLFFLGTISLSLCQDDQERC |
Indosylvirana aurantiaca [Animal] |
Antiviral, Virucidal |
Zika virus (ZIKV) |
20 μM | IC50 / focus-forming assay |
33436917 | - |
YES |
| 420522 | Rec_0433180 | BacYB1 |
VTRASGASTPPGTASPFKTL |
Leuconostoc mesenteroides [Bacterium] |
Antimicrobial, Antifungal, Biocontrol |
Verticillium dahliae |
- | olive-tree Verticillium wilt pot biocontrol assay |
- | - |
YES |
| 420523 | Rec_0433181 | Antioxidant peptide |
DVCGRDVNGY |
Anas platyrhynchus [Animal] |
Antioxidant, DNA-protective |
pBR322 plasmid DNA; H2O2-induced oxidative damage |
- | H2O2-induced plasmid DNA damage protection assay |
- | - |
YES |
| 420524 | Rec_0433182 | sfTSLP |
MFAMKTKAALAIWCPGYSETQINATQAMKKRRKRKVTTNKCLEQVSQLQGLWRRFNRPLLKQQ |
Homo sapiens [Animal] |
Antimicrobial, Antibacterial |
Escherichia coli |
- | 2-h peptide exposure followed by overnight CFU/mL plating assay |
24850429 | - |
YES |
| 420525 | Rec_0433183 | sfTSLP |
MFAMKTKAALAIWCPGYSETQINATQAMKKRRKRKVTTNKCLEQVSQLQGLWRRFNRPLLKQQ |
Homo sapiens [Animal] |
Antimicrobial, Antibacterial |
Enterococcus faecalis |
- | 2-h peptide exposure followed by overnight CFU/mL plating assay |
24850429 | - |
YES |
| 420526 | Rec_0433184 | sfTSLP |
MFAMKTKAALAIWCPGYSETQINATQAMKKRRKRKVTTNKCLEQVSQLQGLWRRFNRPLLKQQ |
Homo sapiens [Animal] |
Antimicrobial, Antibacterial |
Bacillus cereus |
- | 2-h peptide exposure followed by overnight CFU/mL plating assay |
24850429 | - |
YES |
| 420527 | Rec_0433185 | sfTSLP |
MFAMKTKAALAIWCPGYSETQINATQAMKKRRKRKVTTNKCLEQVSQLQGLWRRFNRPLLKQQ |
Homo sapiens [Animal] |
Antimicrobial, Antibacterial |
Staphylococcus epidermidis |
- | 2-h peptide exposure followed by overnight CFU/mL plating assay |
24850429 | - |
YES |
| 420528 | Rec_0433186 | HCC-1[9-74] / CCL14(9-74) |
GPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN |
Homo sapiens [Animal] |
Chemokine, CCR agonist, Chemotactic, Anti-HIV |
human CCR1 |
0.023±0.007 nM | Ki |
11085751 | - |
YES |
| 420529 | Rec_0433187 | HCC-1[9-74] / CCL14(9-74) |
GPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN |
Homo sapiens [Animal] |
Chemokine, CCR agonist, Chemotactic, Anti-HIV |
human CCR1 |
2.8±0.8 nM | EC50 (aequorin functional assay) |
11085751 | - |
YES |
| 420530 | Rec_0433188 | HCC-1[9-74] / CCL14(9-74) |
GPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN |
Homo sapiens [Animal] |
Chemokine, CCR agonist, Chemotactic, Anti-HIV |
human CCR3 |
2.7±0.8 nM | Ki |
11085751 | - |
YES |
| 420531 | Rec_0433189 | HCC-1[9-74] / CCL14(9-74) |
GPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN |
Homo sapiens [Animal] |
Chemokine, CCR agonist, Chemotactic, Anti-HIV |
human CCR3 |
78±14 nM | EC50 (aequorin functional assay) |
11085751 | - |
YES |
| 420532 | Rec_0433190 | HCC-1[9-74] / CCL14(9-74) |
GPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN |
Homo sapiens [Animal] |
Chemokine, CCR agonist, Chemotactic, Anti-HIV |
human CCR5 |
0.04±0.01 nM | Ki |
11085751 | - |
YES |
| 420533 | Rec_0433191 | HCC-1[9-74] / CCL14(9-74) |
GPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN |
Homo sapiens [Animal] |
Chemokine, CCR agonist, Chemotactic, Anti-HIV |
human CCR5 |
4.8±1.2 nM | EC50 (aequorin functional assay) |
11085751 | - |
YES |
| 420534 | Rec_0433192 | C14-GRR-NH2 |
GRR |
synthetic construct [Synthetic] |
Antimicrobial, Hemolytic |
human erythrocytes |
31.94±1.99 μg/mL | HC50 (hemolysis) |
31936341 | - |
YES |
| 420535 | Rec_0433193 | CCH-amide-related peptide 2 |
GGCSAFGHSCFGGH |
Rhodnius prolixus [Animal] |
Neuropeptide |
Rhodnius prolixus Malpighian tubules |
- | Malpighian tubule secretion assay |
31053646 | - |
YES |
| 420536 | Rec_0433194 | LM5 |
AGVKQGWERS |
synthetic construct based on Lactomodulin fragment [Synthetic] |
Antimicrobial, Antibacterial |
Methicillin-resistant Staphylococcus aureus BAA 2313 |
1.4 μM | MIC |
39479472 | - |
YES |
| 420537 | Rec_0433195 | LM5 |
AGVKQGWERS |
synthetic construct based on Lactomodulin fragment [Synthetic] |
Cytotoxic |
NCI-H292 cells |
2.28 μM | EC50 |
39479472 | - |
YES |
| 420538 | Rec_0433196 | LM5 |
AGVKQGWERS |
synthetic construct based on Lactomodulin fragment [Synthetic] |
Cytotoxic |
A549 cells |
11.11 μM | EC50 |
39479472 | - |
YES |
| 420539 | Rec_0433197 | α-Conotoxin MII[L15A] |
GCCSNPVCHLEHSNAC |
synthetic construct [Synthetic] |
Nicotinic acetylcholine receptor antagonist, Neuroactive, Ion channel inhibitory |
rat α3β2 nicotinic acetylcholine receptor |
34 nM | IC50 |
15044624 | - |
YES |
| 420540 | Rec_0433198 | α-Conotoxin MII[L15A] |
GCCSNPVCHLEHSNAC |
synthetic construct [Synthetic] |
Nicotinic acetylcholine receptor antagonist, Neuroactive, Ion channel inhibitory |
rat α6/α3β2β3 nicotinic acetylcholine receptor |
0.92 nM | IC50 |
15044624 | - |
YES |